Containing Coronavirus Through Innovation and Investment: 

An Xconomy Special Report  

Based on pertinent news and analysis as well as discussion from industry experts during the Combatting Coronavirus live panel at BIO-Europe Spring®, this report brings you the latest coronavirus news from the frontlines as top biotech and investment players offer their best plans and current progress in stemming and ultimately defeating the current worldwide pandemic.  

JUST RELEASED: SPECIAL REPORT ON COVID-19   

Xconomy

2 International Place #2610

Boston, MA 02110-4104

The special report includes: 

• Regeneron, Moderna, J&J and the Ongoing Battle Against COVID-19  

• Funding Coronavirus R&D Efforts: Governments and the Private Sector Will Step Up  

• Getting Back to Business: Lessons from China Two Months On 

• Rapid Response Vaccine Capacity Vital for Pandemics, Say Experts 

• Investors Shaken by Coronavirus Sow Seeds of M&A, Financing Slowdown 

• One Billion Doses: CureVac Gains $88m to Support Capacity for COVID-19 mRNA Vaccine